Rex Health Ventures Hero Image
STRATEGIC INVESTMENT.
BREAKTHROUGH INNOVATION.

Rex Health Ventures enables groundbreaking work to advance the future of health

Rex Health Ventures Building

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health.

  • Entrepreneur-friendly strategic investor that speeds access to new healthcare products and services to improve patient care
  • Established by UNC REX Healthcare in 2012 as part of its commitment to innovation, Rex Health Ventures currently operates as the early-stage investment fund for all of UNC Health System
  • Partners with emerging companies throughout North Carolina and the U.S.
  • Leverages the talent and subject matter experts across the UNC REX and UNC Health Care network

Portfolio Spotlight: Phononic

Phononic is revolutionizing cooling and heating with solid-state thermal management solutions. Named to CNBC’s 2016 Disruptor 50 list for its innovation within the cooling and heating industry, as well as CNBC’s Disruptor 50 list for both 2016 and 2017, Phononic provides solid-state semiconductor technology that can be applied to everything from refrigeration to fiber optics, removing the barriers of traditional approaches and ushering in a new era of cooling and heating.

UNC REX served as the first testing site for Phononic’s medical grade refrigerator, which will now be installed throughout the new NC Heart and Vascular hospital. Learn more in this video.

Meet the Rex Health Ventures Team

Anita Watkins

Managing Director

John Perez Rex Health Ventures Healthcare Venture Capital

John Perez

Managing Director

Evan Bernath

Investment Associate

Get the latest investment news from Rex Health Ventures:

Synaptrix scores $10m for postoperative pain relief device

Synaptrix, an Atlanta based medical device startup, announces Series A First-Close of $10M to develop NOVABLOC™, a first-in-kind drug-free solution for extended post-surgical pain relief and elimination of opioids. Proceeds will support a pivotal study, regulatory submission, and commercialization of the company’s proprietary NOVABLOC™ system. The team announced a $10 million Series A last week […]

GI Windows Surgical raises $37M with healthcare providers and leading medtech companies joining forces in the Series B

WESTWOOD, MA, UNITED STATES, November 20, 2024 /EINPresswire.com/ — GI Windows Surgical, Westwood, MA, announced today that it has secured $37 million in additional funding to support the continued clinical development and planned commercialization of its Self-Forming Magnet, FlexagonTM and delivery systems. GI Windows Surgical is engineering a revolutionary technology employing magnetic anastomosis to enable […]

Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309

Financing led by Orlando Health Ventures includes a prominent group of new and existing investorsFunding supports further development of VGT-309 in lung cancer and other solid tumorsFluorescent agent is designed to enhance tumor visualization during minimally invasive and robotic-assisted cancer surgery October 04, 2022 08:00 AM Eastern Daylight Time MINNEAPOLIS–(BUSINESS WIRE)–Vergent Bioscience, a clinical-stage biotechnology […]